15-50997408-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007347.5(AP4E1):c.2429C>T(p.Thr810Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.002 in 1,612,482 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_007347.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4E1 | NM_007347.5 | c.2429C>T | p.Thr810Ile | missense_variant | 18/21 | ENST00000261842.10 | NP_031373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4E1 | ENST00000261842.10 | c.2429C>T | p.Thr810Ile | missense_variant | 18/21 | 1 | NM_007347.5 | ENSP00000261842 | P1 | |
AP4E1 | ENST00000560508.1 | c.2204C>T | p.Thr735Ile | missense_variant | 18/21 | 1 | ENSP00000452976 | |||
AP4E1 | ENST00000558439.5 | c.*1553C>T | 3_prime_UTR_variant, NMD_transcript_variant | 18/21 | 1 | ENSP00000452712 | ||||
AP4E1 | ENST00000561393.5 | c.*1473C>T | 3_prime_UTR_variant, NMD_transcript_variant | 17/20 | 1 | ENSP00000452711 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1692AN: 152146Hom.: 30 Cov.: 32
GnomAD3 exomes AF: 0.00290 AC: 724AN: 249938Hom.: 12 AF XY: 0.00207 AC XY: 280AN XY: 135060
GnomAD4 exome AF: 0.00106 AC: 1542AN: 1460218Hom.: 27 Cov.: 31 AF XY: 0.000880 AC XY: 639AN XY: 726316
GnomAD4 genome AF: 0.0111 AC: 1689AN: 152264Hom.: 28 Cov.: 32 AF XY: 0.0106 AC XY: 791AN XY: 74452
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 08, 2013 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Stuttering, familial persistent, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
AP4E1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hereditary spastic paraplegia 51 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at